UCSF Wins Gold, Silver in International CASE Awards
UCSF won gold and silver medals in an international contest from the Council for Advancement and Support of Education (CASE), which announced its Circle of Excellence awards Wednesday morning.
![](/sites/default/files/styles/news_card__image/public/field/image/news/CASE%20Circle%20of%20Excellence%20Small.jpg)
University of California San Francisco
Give to UCSFUCSF won gold and silver medals in an international contest from the Council for Advancement and Support of Education (CASE), which announced its Circle of Excellence awards Wednesday morning.
The New York Times Health for Tomorrow conference, held at UCSF, featured experts from the University of California and across the country, addressing the changing landscape of health care.
Scientists and physicians at UCSF are leading a $26 million, multi-institutional research program to better understand and treat a range of common, debilitating psychiatric disorders.
Funded through President Obama's Brain Initiative, a UCSF-led team is embarking on a $26 million project to develop a revolutionary and long-lasting treatment for depression, anxiety disorders, addiction and other neuropsychiatric disorders.
UCSF partner choirs at 12 senior centers throughout San Francisco in the “Community of Voices” research study have an opportunity to receive additional funding to sustain these choirs after the study closes.
As players from a wide range of industries continue to venture into health and health care, it will be imperative for UCSF to form new partnerships to address familiar health challenges in creative, novel ways.
A scientific team led by the Gladstone Institutes and UCSF has discovered that a common form of a gene already associated with long life also improves learning and memory.
Young blood really does rejuvenate the brain, at least in mice, raising hopes that molecules in the blood may be identified that can do the same for humans, according to a new UCSF study.
Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as “astrocytes,” because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a new study by UCSF researchers.
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
Four UCSF-affiliated researchers are among 102 recipients of the Presidential Early Career Awards for Scientists and Engineers.
A new online project led by researchers at UCSF promises to dramatically cut the time and cost of conducting clinical trials for brain diseases, while also helping scientists analyze and track the brain functions of thousands of volunteers over time.
The ALS Treatment and Research Center, a clinical practice of the Department of Neurology at UCSF and an ALS Association-certified Center of Excellence, is expanding its support for the community of people facing amyotrophic lateral sclerosis.
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UCSF.
Researchers are recording brain activity in visually stunning ways that could lead to targeted therapies for Alzheimer’s, autism and other diseases.
UCSF neuroscientist Adam Gazzaley, MD, PhD, is hoping to paint a fuller picture of what is happening in the minds and bodies of those suffering from brain disease with his new lab, Neuroscape, which bridges the worlds of neuroscience and high-tech.
The UC San Francisco Department of Radiology and Biomedical Imaging recently won a very competitive grant for traumatic brain injury research. Out of 400 submissions, only 16 proposals received funding.
The Clinical and Translational Science Institute at UCSF has entered into a three-year collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, marking its first industry partnership for CTSI’s Catalyst Awards program’s therapeutic track.
A new study led by researchers from UCSF Benioff Children’s Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy.
UCSF researchers are reporting a detailed account of how speech sounds are identified by the human brain. The finding offers unprecedented insight into the basis of human language and may shed light on language disorders, including dyslexia.
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
Chancellor Susan Desmond-Hellman kicked off a special day-long symposium recognizing the winners of the 2014 Breakthrough Prizes in Life Sciences on Dec. 13. It was the centerpiece of a two-day celebration hosted by UCSF.
Renowned Alzheimer’s researcher and founding president of the UCSF-affiliated Gladstone Institutes, Robert Mahley, MD, PhD, has received a Seeding Drug Discovery Award from the Wellcome Trust.
The nation’s top scientists will gather at UCSF to discuss the latest in research discovery at a special symposium honoring the 2013 and 2014 Breakthrough Prize in Life Sciences Award recipients on Friday, Dec. 13.
The day after the 2014 Breakthrough Prize in Life Sciences winners are announced, the recipients – along with 2013 recipients, UCSF Nobel laureates and other luminaries in the field – will participate in a symposium on the state of research in cancer, genetics, neurobiology and stem cells.
Scientists at the UCSF-affiliated Gladstone Institutes have devised a new molecular sensor that can detect MS at its earliest stages, even before the onset of physical signs.
Join doctors, caregivers, and award-wining poets for a night of poetry, music, and discussion on the end of life.